The mammalian adult brain is generally post-mitotic, but reservoirs of NSCs bearing features of astroglial cells in the hippocampus and SVZ support lifelong neurogenesis^[@R3],[@R4].^. The SVZ is a very active germinal niche in which production of neurons occurs *via* a transit-amplifying progenitor population (TAP)^[@R4]^, giving rise to migrating neuroblasts that integrate into the olfactory bulb (OB) circuitry^[@R5]^. The specialized microenvironment containing niche-astrocytes regulates long-term maintenance of NSCs ensuring continual neurogenesis^[@R3],[@R4],[@R6]^. An emerging hypothesis is that NSCs and niche-astrocytes are established within the postnatal radial glia/astrocytic lineage^[@R7]^, however, the potential lineage relationships and cell-cell interactions between them are not completely understood^[@R6],[@R7],[@R8]^.

*Dlk1* encodes a transmembrane protein belonging to the Notch/Delta/Serrate family of signalling molecules with key roles in differentiation^[@R9]-[@R11]^. *Dlk1* is widely expressed during embryonic development^[@R12]-[@R14]^ and is dosage-sensitive with over-expression causing phenotypes ranging from prenatal lethality to defects in postnatal energy homeostasis^[@R15]^. Few tissues retain *Dlk1* expression postnatally and deletion experiments reveal *in vivo* functions in adipogenesis and haematopoiesis^[@R10],[@R11],[@R16]^. We detected DLK1 in neurogenic areas of the prenatal telencephalon and in the postnatal SVZ with a peak at day 7 (P7). In the adult brain, *Dlk1* expression is mainly restricted to neurons of several areas including the ventral tegmental area^[@R14]^, the septum and the ventral striatum but the protein is still detected in specific cell types of the mature SVZ, in particular NSCs (GFAP^+^/SOX2^+^/Nestin^+^) and niche-astrocytes (GFAP^+^/SOX2^−^/S100β^−^). Differentiated parenchymal astrocytes (GFAP^+^/S100β^+^), βIII-tubulin^+^ neuroblasts and IB4^+^ ependymocytes, are not DLK1^+^ ([Supplementary Fig. 1a-j](#SD1){ref-type="supplementary-material"}).

To test for potential roles for DLK1 in neurogenesis, we analysed brain germinal regions in embryos and postnatal mice harbouring a targeted mutation in the *Dlk1* gene^[@R11]^. Although we observed expression of DLK1 both in progenitor cells and in differentiating neurons in E12.5 and E14.5 ganglionic eminences, we did not observe any differences in progenitor cell activity or in neurogenesis in the mantle between *Dlk1* wild-type and mutant embryos ([Supplementary Fig. 2a-c](#SD5){ref-type="supplementary-material"}), indicating that DLK1 is dispensable during embryonic neurogenesis. In contrast, we observed increased radial glia/NSC activity in the developing SVZ at P7, indicated by higher numbers of GFAP^+^/Ki67^+^ cells resulting in increased doublecortin (DCX)^+^ neuroblasts ([Fig. 1a,b](#F1){ref-type="fig"}; [Supplementary Fig. 3a](#SD6){ref-type="supplementary-material"}), suggesting failure to maintain the slower dividing stem cell pool in the postnatal SVZ.

P7 is a transition time-point between development of the embryonic germinal layer and the mature SVZ^[@R17]^ so we next evaluated adult mice. P60 wild-type and *Dlk1* mutant mice were injected with 5-bromo-2-deoxyuridine (BrdU), and sacrificed one month later to mark BrdU label-retaining cells (LRCs), i.e. relatively quiescent NSCs and cells that abandon the cell cycle shortly after labelling, such as terminally differentiated cells within the SVZ and newly-born OB neurons^[@R18]^. The numbers of BrdU^+^/GFAP^+^/SOX2^+^ or GFAP^+^/Nestin^+^ cells were significantly reduced in *Dlk1*^−/−^ mice ([Fig. 1c,d](#F1){ref-type="fig"}; [Supplementary Fig. 3b,c](#SD6){ref-type="supplementary-material"}). However, the percentage of GFAP^+^/Ki67^+^ cells was similar between genotypes ([Supplementary Fig. 3d,e](#SD6){ref-type="supplementary-material"}), indicating a change in NSC number but not their cycling parameters. Fewer NSCs resulted in fewer MASH1^+^ TAP and DCX^+^ neuroblasts ([Supplementary Fig. 3c, e-f](#SD6){ref-type="supplementary-material"}) resulting in a less densely populated rostral migratory stream ([Fig. 1e](#F1){ref-type="fig"}). Moreover, the numbers of post-mitotic calretinin (CR)^+^ and tyrosine-hydroxylase (TH)^+^ newly-born BrdU^+^ neurons in the granular and periglomerular layers of the mutant OB were significantly reduced ([Supplementary Fig. 1g](#SD1){ref-type="supplementary-material"}).

It has been demonstrated that disruption of quiescence at early postnatal periods leads to loss of stem cell potential and depletion of the NSC pool later in life^[@R19],[@R20]^. To test whether DLK1 was indeed required for NSC maintenance we evaluated the size of the stem cell pool over time by determining primary neurosphere yield at different ages. A transient higher yield in primary neurospheres from P7 SVZ mutant tissue was followed by an increase in their progressive decline as the animals aged ([Fig. 1g](#F1){ref-type="fig"}) suggesting that postnatal expression of DLK1 is required for life-long maintenance of the NSC pool.

To evaluate dosage effects of the *Dlk1* gene, mice carrying the mutation on the maternally (*Dlk1*^−/+^) or the paternally inherited allele (*Dlk1*^+/−^) were analyzed. Interestingly, numbers of GFAP^+^/SOX2^+^/BrdU^+^ LRCs and of newly-generated OB neurons were reduced in both *Dlk1* heterozygotes ([Fig. 1d](#F1){ref-type="fig"}; [Supplementary Fig. 3g](#SD6){ref-type="supplementary-material"}). Consistent with the defects observed *in vivo*, SVZs from *Dlk1*^−/+^, *Dlk1*^+/−^ and *Dlk1*^−/−^ all yielded significantly fewer primary neurospheres than wild-type tissue though brain-size was normal ([Fig. 1f](#F1){ref-type="fig"}; [Supplementary Fig. 3h,i](#SD6){ref-type="supplementary-material"}). We confirmed that these phenotypes were specifically due to a reduction in the available levels of DLK1, by generating paternal transmission *Dlk1* mutants also hemizygous for a *Dlk1* expressing transgene (*Dlk1*^−+/−^;*Dlk1*^*tg*/+^)^[@R15]^. The number of GFAP^+^/SOX2^+^/BrdU^+^ LRCs *in vivo* and *in vitro* neurospheres obtained from double mutant SVZs was not significantly different to their wild-type littermates indicating mutant rescue ([Fig. 1d,g](#F1){ref-type="fig"}).

Despite being reduced in number, mutant neurospheres displayed normal clonogenic capacity upon passage ([Fig. 2a](#F2){ref-type="fig"}), suggesting that DLK1 acts as a postnatal niche-secreted factor *in vivo*. Treatment of P7 and P60 cultures with recombinant mouse DLK1 resulted in 40-50% more neurospheres ([Fig. 2b](#F2){ref-type="fig"}) and significantly higher numbers of secondary spheres were formed from primary neurospheres which had been grown (pre-treated) in DLK1-supplemented medium ([Supplementary Fig. 4a](#SD7){ref-type="supplementary-material"}). These increases were not due to DLK1 promoting NSC survival ([Supplementary Fig. 4b](#SD7){ref-type="supplementary-material"}), suggesting that addition of DLK1 specifically increases self-renewing symmetrical divisions. Moreover, multipotentiality in clonal differentiation assays is increased by exogenous DLK1 ([Fig. 2c](#F2){ref-type="fig"}), further supporting a role for DLK1 as a niche factor. In order to further evaluate this, we co-cultured astrocytes acutely isolated from the SVZs of wild-type, *Dlk1*^−/+^, *Dlk1*^+/−^ and *Dlk1*^−/−^ P7 and P60 mice^[@R8]^ with wild-type NSCs using transwell inserts ([Fig. 2d](#F2){ref-type="fig"}). Wild-type niche-astrocytes induced a significant increase in neurosphere formation which was abrogated when niche-astrocytes were derived from *Dlk1* mutants ([Fig. 2d,e](#F2){ref-type="fig"}). The reduction in neurosphere number in *Dlk1*^−/−^ astrocyte-conditioned medium was rescued by the exogenous addition of recombinant DLK1 ([Fig. 2f](#F2){ref-type="fig"}), an indication that DLK1 secreted by SVZ niche-astrocytes, probably in combination with other niche factors, regulates NSC self-renewal.

Alternatively spliced transcripts of *Dlk1* ([Fig. 3a](#F3){ref-type="fig"}) encoding protein isoforms that are either membrane-tethered or proteolytically-cleaved and secreted, have been described^[@R21]^. Secreted isoforms DLK1A and DLK1B contain a juxtamembrane motif for cleavage by extracellular proteases, absent from membrane-bound DLK1C and DLK1D ([Fig. 3a](#F3){ref-type="fig"}). Secreted isoforms represent the predominant type in acutely isolated niche-astrocytes. Membrane-bound isoforms are preferentially expressed by P7 and P60 NSCs ([Fig. 3b](#F3){ref-type="fig"}). Interestingly, exogenously added DLK1 or co-culture with niche-astrocytes did not increase neurosphere formation in *Dlk1*^−/−^ NSC cultures ([Fig. 2b,e](#F2){ref-type="fig"}) indicating that the membrane-tethered form of DLK1 in NSCs contributes to the response to soluble DLK1.

To confirm whether membrane-bound DLK1 is required for the response to soluble DLK1, GFP-tagged vectors expressing membrane (MB-Dlk1) or secreted (S-Dlk1) isoforms were nucleofected into *Dlk1*^+/+^ and *Dlk1*^−/−^ NSCs, and neurosphere formation in response to exogenous DLK1 was determined. *Dlk1*^−/−^ NSCs regained the response to exogenous DLK1 only when expressing the membrane-bound isoform ([Fig. 3c](#F3){ref-type="fig"}; [Supplementary Fig. 4c,d](#SD7){ref-type="supplementary-material"}). Furthermore, expression of S-Dlk1 but not MB-Dlk1 in *Dlk1*^−/−^ niche-astrocytes rescued wild-type NSC response in co-cultures ([Fig. 3c](#F3){ref-type="fig"}), indicating that membrane-bound DLK1 in NSCs is stimulated by secreted DLK1. Interestingly, increased expression of *Dlk1* above wild-type levels does not influence NSCs response ([Fig. 3c](#F3){ref-type="fig"}; [Supplementary Fig. 4e](#SD7){ref-type="supplementary-material"}). It is worth noting that responses elicited by Jagged1^[@R22]^ and PEDF^[@R23]^ are unperturbed in *Dlk1* mutant NSCs. Moreover, no change was observed in Notch activity after addition of recombinant DLK1 to wild-type NSCs, suggesting a Notch-independent role for DLK1 ([Supplementary Fig. 5a-d](#SD8){ref-type="supplementary-material"}).

*Dlk1*, canonically expressed from the paternally-inherited chromosome, belongs to the *Dlk1-Dio3* imprinted gene cluster on mouse chromosome 12. Northern-blots of adult brain confirmed *Dlk1* transcription from the paternal allele ([Supplementary Fig. 6a](#SD9){ref-type="supplementary-material"}). Moreover, we found low levels of expression of maternal *Dlk1* in paternal heterozygotes supporting canonical expression from the paternal allele in septal neurons and ventral striatum ([Supplementary Fig. 6b,c](#SD9){ref-type="supplementary-material"}). Nonetheless, we had observed similar neurogenic phenotypes in *Dlk1*^−/+^, *Dlk1*^+/−^ and *Dlk1*^−/−^ mutants, and niche-astrocytes from *Dlk1*^+/−^ expressed reduced but detectable levels of DLK1 protein ([Fig. 1d,g](#F1){ref-type="fig"}; [Fig. 2d](#F2){ref-type="fig"}), suggesting a requirement for *Dlk1* from the maternally-inherited allele in postnatal neurogenesis. Consistent with the neurogenesis phenotypes, expression was reduced in *Dlk1*^−/+^, *Dlk1*^+/−^ and *Dlk1*^−/−^ vs. *Dlk1*^+/+^ NSCs and niche-astrocytes, indicating activity from both parental alleles in the neurogenic population ([Fig. 4a](#F4){ref-type="fig"}). We therefore assayed *Dlk1* imprinting in wild-type postnatal and adult F1 hybrid offspring from reciprocal crosses of *Mus musculus domesticus* (C57BL6J) and *Mus musculus castaneus* (Cast/Ei) parents ([Supplementary Fig. 6d](#SD9){ref-type="supplementary-material"}). SVZ tissue from reciprocal hybrids showed the expected paternal expression of *Dlk1* whereas neurospheres and niche-astrocytes showed biallelic expression of both membrane-bound and secreted isoforms ([Fig. 4b](#F4){ref-type="fig"}; [Supplementary Fig.6e](#SD9){ref-type="supplementary-material"}). Importantly, other imprinted genes such as the adjacent *Gtl2* gene, and *Snrpn* on chromosome 7C, maintained imprinting in NSCs and niche-astrocytes ([Fig. 4c](#F4){ref-type="fig"}). To determine if biallelic expression was reflected in DLK1 protein levels *in vivo*, immunostaining in combination with GFAP and SOX2 was performed on maternal and paternal heterozygotes. This confirmed expression of DLK1 from both parental chromosomes in the NSCs of the neurogenic zone ([Fig. 4d,e](#F4){ref-type="fig"}). In contrast, postmitotic neurons in non-neurogenic regions showed clear imprinting of *Dlk1* ([Supplementary Fig. 6b,c](#SD9){ref-type="supplementary-material"}). *Dlk1* was canonically imprinted in NSCs or astrocytes derived from E14.5 embryonic and new-born SVZ, becoming biallelic by P7 ([Supplementary Fig. 6f](#SD9){ref-type="supplementary-material"}). These data demonstrate specific and selective absence of *Dlk1* imprinting in the NSC and niche-astrocyte populations commencing at postnatal stages and continuing to adulthood. This indicates that the mechanism conferring postnatal biallelic expression can override the imprint specifically and selectively at *Dlk1*, and that this regulation is required for normal neurogenesis.

*Dlk1-Dio3* domain imprinting is controlled by the intergenic differentially methylated region (IG-DMR) located between *Dlk1* and the adjacent non-coding RNA gene *Gtl2*^[@R2],[@R24],[@R25]^. This germline-derived mark, characterised by hypomethylation on the maternal chromosome^[@R30]^, is required for post-fertilization acquisition of differential methylation at the secondary Gtl2-DMR at its promoter. Paternal IG-DMR methylation is required for expression of *Dlk1* and repression of *Gtl2* on the paternally-inherited chromosome^[@R26]^. We measured methylation at these DMRs and found no change at the *Gtl2*-DMR, consistent with retention of its imprinting. In contrast, hypermethylation at the IG-DMR was observed in NSCs and niche-astrocytes indicating that absence of *Dlk1* imprinting is associated with gain of methylation at the germ-line DMR postnatally ([Fig. 4f,g](#F4){ref-type="fig"}; [Supplementary Fig. 7a,b](#SD10){ref-type="supplementary-material"}).

In conclusion, our data support a role for DLK1 in a neurogenic continuum initiating at the early postnatal period that is maintained over the lifetime of the aging animal ([Supplementary Fig. 8](#SD11){ref-type="supplementary-material"}). Compromised neurogenesis appears to be driven by an early increase, followed by depletion of the stem cell pool. In the postnatal SVZ, niche-astrocyte-derived soluble DLK1, signals through a membrane-bound form of DLK1 in NSCs to regulate stem cell number with a continued requirement for DLK1 in their maintenance with age. Importantly, our findings indicate that NSCs and niche-astrocytes are distinguished early by expression of DLK1 membrane and secreted isoforms respectively and that differential processing of a single gene confers distinct functional properties to these two cell types. Also noteworthy is the epigenetically regulated selective absence of imprinting resulting in a biallelic dosage of *Dlk1* required for normal neurogenesis. Biallelic expression of imprinted genes in specific cell types may constitute an important regulatory event in their developmental programme. The possibility that loss or gain of genomic imprinting might be used as a dynamic developmental mechanism to control gene dosage has wider implications for our understanding of the function and evolution of imprinting, and implies that the epigenetic mechanisms controlling the process in somatic lineages may be adaptable to the environmental niche in which they are acting.

Methods summary {#S1}
===============

*Dlk1* mutant and transgenic mice were maintained as described^[@R11],[@R15]^. For immunohistochemistry, vibratome sections from 4% paraformaldehyde-fixed brains were used. Neurosphere and primary astrocytes cultures were established as described^[@R6],[@R8]^. DLK1 recombinant protein (ENZO, Life Sciences) was added to medium at the time of seeding. For co-culture experiments, a transwell insert (Millipore) was used and dissociated NSCs were seeded in the upper compartment. Neurospheres were nucleofected using a Mouse NSC Nucleofector Kit (Amaxa Biosystems, Germany) as previously described^[@R23]^. Constructs used were pIRES-GFP empty vector (Invitrogen), pIRES-GFP-S-Dlk1 (S-Dlk1) or pIRES-GFP-MB-Dlk1 (MB-Dlk1). Cells were seeded 48h after nucleofection for neurosphere assessment and immunocytochemistry as previously described^[@R18]^. Antibodies used are noted in [Supplemental Methods](#SD10){ref-type="supplementary-material"}. For qPCR using SYBR Green, RNA was isolated with Trizol (Invitrogen) and reverse-transcribed using SuperScript II RT (Invitrogen). Imprinting assays were based on PCR amplification and sequencing of samples derived from reciprocal F1 hybrid offspring of *Mus musculus domesticus* (C57BL/6) and *Mus musculus castaneus* (Cast/Ei). Bisulfite mutagenesis-based cytosine methylation analysis was as described previously^[@R24]^.

Methods {#S2}
=======

Animals and in vivo manipulations {#S3}
---------------------------------

Generation and genotyping of *Dlk1* mutant and transgenic mice have been described previously^[@R11],[@R15]^. Except for hybrid analyses, experiments were done with mice on a C57BL6 genetic background and their corresponding wild-type littermates. Housing of mice and all experiments were carried out in accordance with UK Government Home Office licensing procedures.

Tissue preparation and Immunohistochemistry {#S4}
-------------------------------------------

BrdU administration regimes have been previously detailed^[@R18]^. Two-to-four month-old mice were injected intraperitoneally with 50 mg BrdU/kg of body weight every 2 hours for 12 consecutive hours (7 injections in total). Animals were deeply anesthetized and transcardially perfused 30 days after the injections with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer pH 7.4 (PB) and their brains were vibratome-sectioned at 40 μm. The sections were blocked in 10% FBS (vol/vol, Invitrogen) and 0.1% Triton X-100 (vol/vol) in PBS (0.9% NaCl in PB) for 1 h and incubated overnight. For embryonic studies pregnant females were injected intraperitoneally with a single injection of 100 mg BrdU/kg body weight and embryos (E12.5 and E14.5) harvested one hour later. Embryonic and postnatal brains were dissected in PBS and fixed for 2h in 4% PFA at 4°C. Fixed samples were cryoprotected overnight in 20% sucrose/PBS at 4°C and mounted in OCT Compound (VWR) and sectioned coronally (20 μm) with a cryostat (CM3050S, Leica). For immunohistochemistry, cryostat sections were washed in PBS, and blocked at room temperature for 1 h in PBST (PBS, 0.1% Triton X-100) supplemented with 10% goat serum (Vector Laboratories). Primary antibodies and dilutions used were: mouse anti-BrdU (1:250; Dako), Ki67 (1:200; Novocastra), βIII-tubulin (1:250; Covance), Nestin (1:500, Chemicon) or Mash1 (1:100; Beckton Dickinson), goat anti-Sox2 (1:100; R&D Systems) or Doublecortin (DCX; 1:300; Santa Cruz), rabbit anti-GFAP (1:500; Dako), S100β (1:100, Dako), Tyrosine Hydroxylase (TH; 1:2000; Sigma), Calretinin (CR; 1:4000; Swant) or pH3 (1:500; Upstate) and rat anti-DLK1 (1:100; ENZO Life Sciences). For ependymal cell detection *in vivo*, sections were labeled with fluorescein isothiocyanate (FITC)-conjugated lectin IB4 (Sigma; 1:1,000). For BrdU detection sections were pre-incubated in 2 N HCl for 30 min at 37 °C and neutralized in 0.1 M sodium borate (pH 8.5). Secondary antibodies Alexa 488-conjugated donkey anti-mouse, Alexa 488-conjugated anti-rat, Alexa 647-conjugated donkey anti-rabbit (Molecular Probes), and CY3-conjugated donkey anti-goat (Jackson ImmunoResearch Laboratories) were used at 1:500 for 1 h. Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI; 1 mg/ml). For DLK1 staining *Dlk1*^−/−^ SVZ sections or cultures were used to confirm antibody specificity. Inmunofluorescence was analyzed using a Leica Multispectral confocal microscope (Leica). For SVZ whole-mounts we used protocols established previously^[@R27]^. Briefly the lateral walls of the lateral ventricle were dissected out and the resulting whole mounts were fixed for 1.5 hr in 4% paraformaldehyde and washed overnight at 4°C in PBS. For DCX staining, whole mounts were washed 3 times in PBS containing 0.5% Triton X-100 for 15 min each, blocked for 2 hr in blocking solution (10% FBS (vol/vol) and 0.5% Triton X-100 (vol/vol) in PBS (0.9% NaCl in PB), incubated for 72 hr at 4°C in goat anti-DCX (1:500 dilution; Santa Cruz). Secondary antibody Alexa 488-conjugated anti-goat (Jackson ImmunoResearch Laboratories) was used at 1:500. The stained walls were mounted with Fluorsave (Calbiochem) between two coverslips.

Neural Stem Cell and primary astrocyte cultures {#S5}
-----------------------------------------------

Methods for NSC culture and self-renewal assessment, as well as BrdU immunocytochemistry in neurosphere cultures, have been previously described in detail^[@R18]^. Single cells from SVZ dissociates were seeded at very low density (2.5 cell/μl) in neurosphere growth medium with EGF and FGF which was supplemented with recombinant DLK1 (mouse):Fc (human) protein (2-100 ng/ml; produced in HEK 293 cells; ENZO Life Sciences), Jagged1 (1 μg/ml; Calbiochem), or PEDF (50 ng/ml; Bioproducts MD), and analyzed for primary neurosphere formation after 5 days *in vitro*. For self-renewal assays primary spheres formed in any condition were treated with Accutase (0.5 mM; Sigma) for 10 min, mechanically dissociated to a single-cell suspension and re-plated in growth medium containing EGF and FGF. Cell apoptosis and viability in single cells and incipient neurospheres were determined at 24 and 72 hours after plating, as previously described^[@R23]^. Multipotency capacity was analyzed by seeding individual passage 2-3 neurospheres of similar sizes in Matrigel-coated 96-well plates for 7 days *in vitro* (2% fetal bovine serum, vol/vol) before fixation in 4% PFA. No less than 50 clones were analyzed for each condition and the experiment as was previously described^[@R23]^. Distribution of unipotent (A, Astrocytes GFAP+), bipotent (A/N, GFAP+ Astrocytes and βIII-tubulin+ Neurons) and tripotent (A/N/O, GFAP+ Astrocytes, βIII-tubulin+ Neurons and O4+ Oligondendrocytes) clones was determined. To generate primary astrocyte cultures we used established methods as described previously by the Gage laboratory and others^[@R6],[@R28],[@R29]^. Importantly, no sub-culturing was made to the astrocyte cultures that were used for co-culture experiments. In brief, isolated adult SVZs were transferred to EBSS containing 1.0 mg/ml papain (Worthington DBA), 0.2 mg/ml L-cystein (Sigma), and 0.2 mg/ml EDTA (Sigma) and incubated in this mixture for 30 min at 37 °C. Tissue was then rinsed in DMEM/F12 medium (1:1 v/v; Invitrogen) and carefully triturated with a fire-polished Pasteur pipette to a single cell suspension. Isolated cells were collected by centrifugation, resuspended in astrocyte medium (DMEM/F12 medium containing 2 mM L-glutamine, 0.6% glucose, 9.6 g/ml putrescine, 6.3 ng/ml progesterone, 5.2 ng/ml sodium selenite, 0.025 mg/ml insulin, 0.1 mg/ml transferring and supplemented with 10% fetal bovine serum). Single cell suspensions from the SVZ were seeded onto Matrigel (1x; Becton Dickinson) treated wells in astrocyte medium and cultured in 37 °C incubator with 5% CO~2~ until astrocytes reached confluence (approx 6 days). The medium was changed every 2 days. The flasks were then shaken at 100 rotations per min for 3 hours at room temperature to shake off proliferating cells, oligodendrocyte progenitors and neurons. For co-culture experiments, the astrocyte culture medium was changed to neurosphere growth medium with mitogens and 2 h afterwards, a transwell insert (0.4-μm pore; 12-mm diameter; Millipore) was placed above and dissociated NSCs were seeded in the upper compartment. The astrocyte purity of the cultures was established by immunostaining against GFAP. Primary antibodies and dilutions used *in vitro* were: mouse anti-BrdU (1:500; Dako), O4 (1:2, Developmental Studies Hybridoma Bank) or βIII-tubulin (1:300; Covance), rabbit anti-GFAP (1:700; Dako), NICD (1:200, Abcam) or Caspase 3 (1:300, Cell Signaling), and rat anti-DLK1 (1:100; ENZO Life Sciences). Secondary antibodies Alexa 488-conjugated donkey anti-mouse, Alexa 488-conjugated anti-rat, Alexa 647-conjugated donkey anti-rabbit (Molecular Probes), and CY3-conjugated donkey anti-goat (Jackson ImmunoResearch Laboratories) were used at 1:500 for 1 h. DAPI (1 mg/ml) was used for counterstaining.

Cell transduction and luciferase assays {#S6}
---------------------------------------

Constructs representing the predominant forms of *Dlk1* generated by alternate splicing and proteolysis were generated previously^[@R21]^. We subcloned them in a pIRESh-GFPII vector (Invitrogen). NSCs grown for 2 days (passage 4--6) were nucleofected with 2--4 μg pIRESh-GFPII empty vector, pIRESh-GFPII-S-Dlk1 (S-Dlk1; secreted form, contains sequences from full length *Dlk1A* up to the juxtamembrane cleavage domain (amino acid 303) or pIRESh-GFPII-MB-Dlk1 (MB-Dlk1; membrane-bound form, lacks coding sequence for the juxtamembrane motif, amino acids 230-303, that is the substrate for cleavage and so represents *Dlk1C*) using a Mouse NSC Nucleofector Kit (Amaxa Biosystems, Germany) as described by the manufacturer. Cells were dissociated 2 days after nucleofection and seeded at low-density (2.5 cells per μl) in 96-well plates for neurosphere assessment. In reporter assays with a firefly luciferase-based construct we electroporated 2-4 μg of DNA from the construct *4xwtCBF1-luc*^[@R30]^ and 50 ng of a *Renilla* luciferase construct as internal control. After 24--36 h, transduced cells (passage 4--6) were dissociated, plated in the presence or absence of DLK1 (ENZO; 50 ng/ml) or PEDF (100 ng/ml) as a positive control, and cultured for 24 h before being harvested for analysis. Efficiency was around 80% in all cases. Luciferase activity was measured in cell lysates using the Dual Luciferase Assay System (Promega) and promoter activity was defined as the ratio between the firefly and *Renilla* luciferase activities.

Expression Studies {#S7}
------------------

RNAs were extracted with Trizol (Invitrogen), following manufacturer's guidelines. For Northern blots mRNA was isolated from 75 μg of total RNA using Dynabeads Oligo (dT)~25~ kit (Invitrogen) following the supplied protocol. We used probes as described previously for *Dlk1* and *Gapdh*^[@R2]^. For quantitative PCR (qPCR) 1 μg of total RNA was DNase-treated with RQ1 RNase-free DNase (Promega) following the manufacturer's guidelines. All cDNA was synthesized using random primers and SuperScript II RT reverse transcriptase (Invitrogen), following standard procedures. Quantitative PCR was used to measure expression levels of *Dlk1* normalized to *Gapdh* and was performed on a DNA Engine 2 Opticon detection system (Bio-Rad) using SYBR Green I as a double-strand DNA-specific binding dye. Thermocycling was performed in a final volume of 20 μl containing 2 μl of cDNA sample (diluted 1:5), 20 pmol of each primer (*Dlk1-F*, 5′-GAAAGGACTGCCAGCACAAG-3′; *Dlk1-R*, 3′-CACAGAAGTTGCCTGAGAAGC-5′; *Gapdh-F*, 5′-CCATCACCATCTTCCAGGAG-3′, *Gapdh-R*, 5′-GCATGGACTGTGGTCATGAG-3′), 2 mM MgCl~2~, 0.2 mM dNTP mixture, 1X Taq reaction buffer, 0.5 U HotStart Taq DNA polymerase, and 0.5 μl of a 1:3000 dilution of SYBER Green I. Semi-quantitative PCR (sqPCR) was performed to determine the different *Dlk1* isoforms, and levels of transcripts were quantified by densitometric analysis of PCR bands in ethidium bromide-stained electrophoresis gels and normalized to *Gapdh* levels obtained at 20 cycles. Primers used were: *Dlk1Splice-F*, 5′-CTGCACACCTGGGTTCTCTG-3′; *DlkSplice-R*, 3′-TCCTCATCACCAGCCTCCTT-5′. *In situ* hybridization was conducted on PFA-fixed 40 μm vibratome adult brain sections according to procedures previously described^[@R15]^.

Imprinting assays {#S8}
-----------------

All imprinting assays were based on PCR amplification followed by direct sequencing to analyze parental specific expression of the genes. PCR reactions were purified with the QiAquick kit (Qiagen) prior to sequencing. We used reciprocal F1 hybrid offspring *Mus musculus domesticus* (strain C57BL/6, abbreviated BL6) and *Mus musculus castaneus* (strain Cast/Ei, abbreviated Cast) subspecies in which we had identified a single-nucleotide polymorphism between the two subspecies. The sequences of murine *Dlk1* were obtained from GenBank (Accession number: NM010052). The *Dlk1* polymorphism, located at exon 6 nucleotide 721, is a 'T' in BL6 mice and a 'C' in Cast mice. The *Dlk1* imprinting assay used the following primers to amplify a fragment between exons 4 and 5: *Dlk1-F*, 5′-ACCCCCTGCGCCAACAATGG-3′ and *Dlk1-R*, 3′-GGGGTGAAGGGCCTGGGGAGT-5′, with thermal cycler conditions 94°C 1 min, 60°C 1 min, 72°C 1 min for 30 cycles. Primer *Dlk1seq*, 5′-AGAAGAAGAACCTCCTGTTGCA-3′, was used for direct reverse PCR fragment sequencing. The sequences of murine *Gtl2* were obtained from GenBank (Accession number: Y13832). The *Gtl2* polymorphism, located at exon 8, nucleotide 26, is a 'G' in BL6 mice and an 'A' in Cast mice. The *Gtl2* imprinting assay used the following primers to amplify a fragment between exons 6 and 8: *Gtl2-F*, 5′-CTTGCTGGCCCTGGAGAT-3′and *Gtl2-R*, 3′-AACGTGTTGTGCGTGAAGTC-5′ with thermal cycler conditions 94°C 1 min, 59°C 1 min, 72°C 1 min for 33 cycles. Primer *Gtl2-R* was used for direct sequencing. The sequences of murine *Snrpn* were obtained from GenBank (Accession number: NM013670). The *Snrpn* polymorphism, located at exon 10 nucleotide 1270 is a 'C' in BL6 mice and a 'T' in Cast mice. The *Snrpn* imprinting assay used the following primers to amplify a fragment between exons 9 and 10: *Snrpn-F*, 5′-CATTATGGCTCCTCCACCTG-3′ and *Snrpn-R*, 3′-GTACCTGCAAGCTTTTTGACCC-5′, with thermal cycler conditions 94°C 1 min, 61°C 1 min, 72°C 1 min for 30 cycles. Primer *Snrpn-F* was used for direct sequencing. Genomic DNA sequences traces from BL6 and Cast SVZ, were used to identify strain-specific polymorphisms. ([Supplementary Fig. 6d](#SD9){ref-type="supplementary-material"}).

Combined bisulfite restriction analysis (COBRA) and pyrosequencing {#S9}
------------------------------------------------------------------

DNA methylation level was quantified using COBRA and pyrosequencing. The method for bisulfite-based cytosine methylation analysis was adapted from Takada *et al*., 2002^[@R24]^. DNA was denaturated by adding NaOH to a final concentration of 0.4 N. After 15 min incubation at 50°C, DNA was treated with 5 M sodium bisulfite/100 mM hydroxyquinone and incubated 18 h at 50°C. DNA was then desalted with Qiaquick PCR purification Kit (Qiagen) according manufacturer and desulphonated by adding NaOH to a final concentration of 0.3 N and incubating it 15 min at 37°C. DNA was finally neutralized and precipitated by adding 10 μg pf glycogen, 3 M of ammonium acetate and 200 μl of absolute ethanol and by incubating it overnight at −20°C. To generate the product for each target two rounds of PCR were done with fully or semi-nested primer pairs. Primers set for *Gtl2* DMR (intron 1) were CT-F1 (5′-TGG TTT GGG GGT AGT TTT TTA TTG TAG-3′) and CT-R1 (5′-AAA AAA TAC AAA TAA ATT AAT TAA CAA ATC ACA AA -3′) for the first PCR. For the second round of PCR the following primers were used: CT-F2 (5′-ATT TTT AAA GAT GGT TGA TGT GGG TTT-3′) and CT-R1. Primers set for *Gtl2* DMR (promoter) were GPFO (5′-TTT TAT TTA TAA TTA GGG TTT ATG TAG GGA AA-3′) and GPR3 (5′-TCT TCA TTT TTA CAC ATC CTT TCA AA-3′) for the first PCR and GPF2 (5′-GTA ATT TGT TAT AGA TTG GGG GGT TT-3′) and GPR4 (5′-CTT TCA AAC AAA AAA TAA CTA ACC ACT CAC CAA-3′) for the second round PCR. Primers for the IG-DMR first round PCR were IGOF (5′-GTG TTA AGG TAT ATT ATG TTA GTG TTA GG-3′) and IGOIR (5′-TAC AAC CCT TCC CTC ACT CCA AAA ATT-3′) and for the second round PCR IGIF (5′-ATA TTA TGT TAG TGT TAG GAA GGA TTG TG-3′) and IGOIR. First and second PCRs were run in 25 μl in the presence of 2U of HotStar Taq polymerase (Qiagen), 1X manufacture's buffer, 3 mM MgCl2, 400 μM dNTPs and 1μM primers. PCR conditions were 10 cycles at 95°C for 40 secs, 53°C.for 40 secs and 72°C for 1 min followed by 30 cycles of 95°C for 30 secs, 53°C.for 30 secs and 72°C for 1 min. The PCR products were digested with appropriate restriction enzymes (RE) for combined bisulfite restriction analysis, representing each enzyme a representative methylation site. For IG-DMR NruI, Sau3AI and MluI were used; for Gtl2 DMR HincII, HpyCH4IV and for Gtl2 intron 1, HhaI and HpyCH4IV. MseI was used in all reaction as a bisulfite conversion control. The entire process was repeated three times and produced similar results. For pyrosequencing analysis a biotin-labeled primer was used to purify the final PCR product using Sepharose beads. The PCR product was bound to Streptavidin Sepharose High Performance (Amersham Biosciences), purified, washed, denatured with 0.2 mol/L NaOH, and washed again. Pyrosequencing primer (0.3 μM) was then annealed to the purified single-stranded PCR product and pyrosequencing was performed using the PyroMark Q96MD pyrosequencing system (Qiagen, Germany). Primers used: IG-DMR-F: 5′-GTGGTTTGTTATGGGTAAGTT-3′ and IG-DMR-R: 5′-CCCTTCCCTCACTCCAAAAATT-3′.

Statistical analyses {#S10}
--------------------

All statistical tests were performed using the GraphPad Prism Software version 4.00 for Windows, GraphPad Software, San Diego California USA ([www.graphpad.com](http://www.graphpad.com)). The significance of the difference between groups was evaluated by analysis of variance followed by a two-tailed Student's *t*-test in all experiments. When comparisons were performed with relative values (normalized values and percentages), data were first normalized by using an arcsen transformation. Treatment experiments were analyzed by Paired-T Test. Data is presented as the mean ± standard error of the mean (s.e.m) and the number of experiments performed with independent cultures/animals (n) is indicated in the legends.
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![DLK1 regulates postnatal neurogenesis\
**(a)** Immunohistochemistry for GFAP (green) and Ki67 (red) within the postnatal 7 (P7) SVZ of wild-type and *Dlk1*^−/−^ mice. **(b)** Percentage of cell-types in the P7 SVZ from wild-type and *Dlk1*^−/−^ mice. **(c)** Immunohistochemistry for GFAP (blue), SOX2 (red) and BrdU (green) within the adult SVZ of wild-type and *Dlk1*^−/−^ mice. **(d)** Number of GFAP^+^/SOX2^+^/BrdU-label retaining cells (LRC)^+^ in the SVZ of mice with deletions of maternally-inherited (*Dlk1*^−/+^), paternally-inherited (*Dlk1*^+/−^), or both alleles (*Dlk1*^−/−^). Light-green bar represents paternal transmission mutant mice in a *Dlk1* transgenic background (*Dlk1*^+/−^/*Dlk1*^*tg*/+^). **(e)** Whole-mount for DCX+ migrating neuroblasts within the SVZ. **(f)** Primary spheres from wild-type and *Dlk1* mutant SVZs at different developmental stages. **(g)** Primary spheres from adult SVZ of different *Dlk1* mutants. \**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001. Error bars, s.e.m. of five experiments (n=4 cultures *per* genotype). V, ventricle. Scale bars; in **a, c,** 20 μm (inset 10 μm).](ukmss-36010-f0001){#F1}

![DLK1 is secreted by postnatal SVZ niche-astrocytes\
**(a)** Secondary spheres formed from wild-type and *Dlk1*^−/−^ primary neurospheres at P7 and P60. **(b)** Primary spheres from *Dlk1*^+/+^ and *Dlk1*^−/−^ SVZ, after DLK1 treatment. **(c)** Quantification of unipotent (astrocytes), bipotent (astrocytes/neurons) and tripotent (astrocytes/ neurons/oligondendrocytes) clones derived from *Dlk1*^+/+^ and *Dlk1*^−/−^ neurospheres grown in the presence or absence of DLK1 (left panel). Immunocytochemistry for GFAP (red), βIII-tubulin (green) and O4 (yellow) in differentiated neurospheres (right panel). **(d)** Primary neurospheres co-cultured with wild-type or *Dlk1* mutant niche-astrocytes (upper panels). Immunocytochemistry for GFAP (red) and DLK1 (green) in niche-astrocyte cultures (lower panels). **(e)** Quantification of P7 and P60 co-culture experiments shown in d. **(f)** Primary spheres co-cultured with *Dlk1*^+/+^ or *Dlk1*^−/−^ astrocytes and treated with DLK1. Dashed-lines indicate non co-cultured spheres. \**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001. Error bars, s.e.m of triplicate cultures (3-6 samples per genotype). Scale bars: in **c**, 50 μm; in **d** (upper panel, 100 μm; lower panel, 30 μm).](ukmss-36010-f0002){#F2}

![NSCs require membrane-bound DLK1 to respond to niche-secreted DLK1\
**(a)** *Dlk1* transcripts in whole brain. Proteolytic cleavage domain (grey box) is shown. **(b)** Semi-quantitative PCR of *Dlk1* isoforms in SVZ, NSCs and niche-astrocytes at postnatal 7 and 60. **(c)** Neurospheres generated from *Dlk1*^−/−^ or *Dlk1*^+/+^ cultures nucleofected with pIRES-GFP, pIRES-GFP-S-*Dlk1* (secreted isoform) or pIRES-GFP-MB-*Dlk1* (membrane-bound isoform) after DLK1 treatment or from wild-type NSCs co-cultured with transduced *Dlk1*^−/−^ astrocytes. **(d)** Semi-quantitative PCR of *Dlk1* isoforms in nucleofected NSCs. \*\**p*\<0.01, \*\*\**p*\<0.001. Error bars: s.e.m; triplicate cultures (n=6 animals *per* genotype).](ukmss-36010-f0003){#F3}

![NSCs and niche-astrocytes selectively lose *Dlk1* imprinting postnatally\
**(a)** Quantitative PCR of *Dlk1* expression in SVZ, NSCs and niche-astrocytes derived from *Dlk1*^+/+^, *Dlk1*^−/+^ and *Dlk1*^+/−^ mice. **(b)** *Dlk1* allele-specific expression of postnatal 7 and 60 SVZ, NSCs, and niche-astrocytes derived from reciprocal F1 hybrid offspring from *Mus musculus domesticus* (BL6) and *Mus musculus castaneus* (Cast). **(c)** *Gtl2* and *Snrpn* allele-specific expression. **(d)** Immunohistochemistry for GFAP (red) and DLK1 (green) in the SVZ of *Dlk1*^+/+^, *Dlk1*^−/+^ and *Dlk*^+/−^ mice. **(e)** Immunohistochemistry for GFAP (blue), SOX2 (red), and DLK1 (green) in the SVZ of *Dlk1* mutant mice. Arrowheads indicate positive cells. **(f)** Methylation at the IG-DMR and Gtl2 promoter DMR. **(g)** Schematic representation of the Dlk1-Gtl2 domain in the neurogenic niche. Open and closed circles represent unmethylated and hypermethylated CpGs respectively. \**p*\<0.05, \*\**p*\<0.01. Error bars: s.e.m; n=10 per group and three bisulfite conversions. Scale bars: in **c**, 10 μm; in **d**, 7 μm.](ukmss-36010-f0004){#F4}
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